US approval will decide the fate of this stock. The product is good, but local trials still need to be executed correctly to obtain the approval. Additional expertise has been recruited to the management team and the board; let’s see how they perform. It will likely take a couple more years. At what stage and with what probability the market will start front-running the future remains to be seen.
1 Like